Proto Labs (PRLB) Common Equity (2011 - 2026)

Proto Labs has disclosed Common Equity across 16 years of filings, most recently posting $691.7 million for Q2 2026.

• In Q2 2026, Common Equity rose 4.07% year-over-year to $691.7 million; the TTM figure through Jun 2026 stood at $691.7 million (up 4.07% YoY), while the FY2025 annual figure was $673.9 million, up 0.56% from the prior year.
• Common Equity came in at $691.7 million for Q2 2026 at Proto Labs, up from $683.1 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $832.0 million in Q1 2022 to a low of $656.8 million in Q1 2025.
• Average Common Equity over 5 years is $703.6 million, with a median of $684.0 million recorded in 2023.
• Year-over-year, Common Equity dropped 17.9% in 2023 and increased 4.07% in 2026.
• Over 5 years, Common Equity stood at $697.6 million in 2022, then slipped by 0.34% to $695.3 million in 2023, then declined by 3.62% to $670.2 million in 2024, then grew by 0.56% to $673.9 million in 2025, then advanced by 2.64% to $691.7 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $691.7 million in Q2 2026, $683.1 million in Q1 2026, and $673.9 million in Q4 2025.